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Background: We previously showed by immunofluorescence (IF) that both ApoB100-containing hepatic and ApoB48-containing intestinal particles 
localize in human carotid atherosclerotic plaques. Here we expand on this by immuno-electron microscopy (IEM).
Methods: Human small intestinal tissue and 4 carotid endarterectomy specimens were prepared for IF and IEM. For IEM, immunogold labeling was 
done on samples fixed overnight with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) and embedded in LR white resin. Labeling procedure 
involved overnight incubation of primary antibodies diluted 1:100 in PBS containing 0.1% acetylated BSA and 2 hrs for the secondary antibody 
conjugated to 10 nm colloidal gold particles. Ultrathin sections were examined on a transmission electron microscope. Antibodies were same for IF 
and IEM. For B100 we used a commercial antibody recognizing the C-terminal portion (Abcam 50069, rabbit polyclonal); for B48 we used a murine 
monoclonal antibody (4C8) recognizing the C-terminal; this region is conformationally hidden in B100, preventing cross-reaction.
Results: IEM confirmed the presence of B100 and B48 in enterocytes (A, B). In plaques, IF showed differential localization of B48 and B100; B48 was 
subendothelial and in necrotic core (C, D). IEM showed B48 within the cells (E) and in acellular regions; B100 was mostly in acellular regions (F).
Conclusions: This is the first demonstration by IEM that both hepatic and intestinal particles contribute to human atherosclerosis.
